DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
Condition: Motion Sickness Interventions: Drug: DPI-386 Nasal Gel; Drug: DPI-386 Placebo Nasal Gel; Drug: Transderm Scop® Sponsor: Repurposed Therapeutics, Inc. Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Motion Sickness | Research